Gerald L. Chan

Gerald R. Chan, Sc.D. has served as a member of the LumiraDx board of directors since September 2020. Since 2006, Dr. Chan has served as the Managing Director, Business Consulting Services for Morningside Technology Advisory, LLC. Dr. Chan has served as a director of Stealth BioTherapeutics Corp. (Nasdaq: MITO) since July 2013 and was previously a director of Aduro Biotech Inc. (Nasdaq: ADRO) from 2014 to 2018. He also serves as a director of several privately-held life sciences companies. Dr. Chan received a B.S. and an M.S. in engineering from the University of California, Los Angeles, and a M.S. in medical radiological physics and a Sc.D. in radiation biology from Harvard University. He did his post-doctoral training at the Dana-Farber Cancer Institute as a fellow of the Leukemia Society of America.